Even though the HMOs did show beneficial effects on allergy biomarkers in the murine model for ovalbumin-induced food allergy, the allergic sensitization (OVA-IgE) and systemic allergic symptoms scores were not prevented. This evidence concerns the gene IGHE and food allergy.